Release Date: 31/10/19 17:12 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 14.45MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%